All In Biotech

Drug Trial Radar · NCT00029848

Obese Patients With Type 2 Diabetes

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose, Multicenter Study of Weight-Reducing Effect and Safety in Obese Patients With Type 2 Diabetes

Last checked: Nov 20, 2026Latest source record: Apr 20, 2009 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 1,045 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,045

Actual

Start

Oct 2001

Primary completion

May 2004

Study completion May 2004

Sponsor

Lead sponsor
SanofiSanofi (SNY)
Sponsor type
Industry
First posted
Jan 24, 2002

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To assess the effect on weight loss and weight maintenance over a period of one year when prescribed with a hypocaloric diet in obese patients with Type 2 Diabetes

Conditions

  • Obesity
  • Diabetes Mellitus, Non-Insulin-Dependent
  • Obesity in Diabetes

Interventions

  • Rimonabant (SR141716)Drug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in body weight

Locations

55 sites in 11 countries. Site status is shown where the registry gives one.

  • Innovative Clinical Trials

    Birmingham, Alabama

  • Lovelace Scientific Resources

    Phoenix, Arizona

  • Advanced Clinicla Therapeutics, LLC

    Tucson, Arizona

  • Southern California Prevention and Research Center Inc. (SPARC)

    Encino, California

  • Anderson Clinical Research

    San Bernardino, California

  • Diablo Clinical Research, Inc.

    Walnut Creek, California

  • North East Clinical Research

    Hamden, Connecticut

  • Clinical Research of South Florida

    Coral Gables, Florida

  • Jackson Downey, MD

    Jacksonville, Florida

  • Jacksonville Center for Clinical Research

    Jacksonville, Florida

  • Jacksonville Center for Clinical Research

    Jacksonville, Florida

  • DMI Helathcare Group

    Largo, Florida

  • Orlando Clinical Research Center

    Orlando, Florida

  • University Clinical Research

    Pembroke Pines, Florida

  • Comprehensive NeuroScience, Inc.

    Sarasota, Florida

  • Metabolic Research Institute

    West Palm Beach, Florida

  • CSRA Partners in Health, Inc.

    Augusta, Georgia

  • nTouch Research

    Marietta, Georgia

  • MediSphere Medical Research Center, LLC

    Evansville, Indiana

  • Physicians Research Group

    Indianapolis, Indiana

  • Kansas University Medical Center

    Kansas City, Kansas

  • Gulf States Clinical Trails, LLC

    Kenner, Louisiana

  • Medical Research Institute

    Slidell, Louisiana

  • Androscoggin Cardiology Associates

    Auburn, Maine

  • Phase III Clinical Research

    Fall River, Massachusetts

  • JM Clinical Trials, Inc.

    Swansea, Massachusetts

  • Twin Cities Clinical Research

    Arden Hills, Minnesota

  • Lovelace Scientific Resources

    Las Vegas, Nevada

  • Endocrinology and Diabetes Consultants, PC

    Dover, New Hampshire

  • Radiant Reseach-Moorestown

    Moorestown, New Jersey

  • Lovelace Scientific Resources

    Albuquerque, New Mexico

  • Physician Clinical Research Service

    White Plains, New York

  • Center for Nutrition and Preventive Medicine

    Charlotte, North Carolina

  • Radiant Research

    Cincinnati, Ohio

  • MFP Research, Inc.

    Cincinnati, Ohio

  • University of Oklahoma Health Sciences Center

    Oklahoma City, Oklahoma

  • Radiant Research

    Portland, Oregon

  • Medical University of South Carolina, Division of Clinical Pharmacology

    Charleston, South Carolina

  • Costal Carolina Research Center

    Mt. Pleasant, South Carolina

  • TriCities Medical Reseach

    Bristol, Tennessee

Showing 40 of 55 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.